Paul Rivard My Md Pharmaceuticals, Inc. (MYMD) insider trading activity

MYMD Quotes by TradingView

Paul Rivard is Chief Legal Officer of MyMD Pharmaceuticals, Inc.. Currently has a direct ownership of 400,000 shares of MYMD, which is worth approximately $684,000. The most recent transaction as insider was on Aug 24, 2023, when has been sold 150,000 shares (Common Stock) at a price of $1.11 per share, resulting in proceeds of $166,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 400K
0% 3M change
0% 12M change
Total Value Held $684,000

Paul Rivard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 24 2023
BUY
Open market or private purchase
$166,500 $1.11 p/Share
150,000 Added 27.27%
400,000 Common Stock
Aug 17 2023
BUY
Open market or private purchase
$28,000 $1.12 p/Share
25,000 Added 9.09%
250,000 Common Stock
Dec 08 2022
BUY
Open market or private purchase
$15,300 $1.53 p/Share
10,000 Added 4.26%
225,000 Common Stock
Nov 23 2021
BUY
Open market or private purchase
$90,450 $6.03 p/Share
15,000 Added 6.52%
215,000 Common Stock
PR

Paul Rivard

Chief Legal Officer
New York,, NY

Track Institutional and Insider Activities on MYMD

Follow MyMD Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYMD shares.

Notify only if

Insider Trading

Get notified when an My Md Pharmaceuticals, Inc. insider buys or sells MYMD shares.

Notify only if

News

Receive news related to MyMD Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MYMD